First‐line <scp>PD</scp> ‐1/ <scp>PD‐L1</scp> inhibitors plus chemotherapy versus bevacizumab plus chemotherapy for advanced non‐squamous non‐small cell lung cancer: A Bayesian network meta‐analysis of randomized controlled trials-Reference-Cited by-同舟云学术

First‐line PD ‐1/ PD‐L1 inhibitors plus chemotherapy versus bevacizumab plus chemotherapy for advanced non‐squamous non‐small cell lung cancer: A Bayesian network meta‐analysis of randomized controlled trials

Published:2022-03-22 Issue:10 Volume:11 Page:2043-2055
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Zhai Jinzhao¹²^ORCID,Lu Jiangyue³,Zhang Zhibo⁴^ORCID,Wang Yuan⁵,Li Xiaoyan¹,Zhang Sujie¹,Mu Shuai¹,Zhi Xiaoyu¹²^ORCID,Ge Xiangwei¹²,Lu Di¹²^ORCID,Hu Yi¹,Wang Jinliang¹

Affiliation:

1. Senior Department of Oncology The 5th Medical Center of Chinese PLA General Hospital Beijing China

2. Medical School of Chinese PLA Beijing China

3. Harbin Medical University Cancer Hospital Harbin China

4. The 78th Group Army Hospital of Chinese PLA Mudanjiang China

5. Haidian No. 23 Cadre's Sanitarium of Chinese PLA Beijing China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4589